David Shaw D.E. Shaw & Co
David Shaw founded D. E. Shaw & Co., a pioneering quantitative investment firm that helped define systematic trading at scale. With a background in computer science, Shaw built teams that applied advanced computation to markets across equities, derivatives, and other assets. The firm remains one of the most important quant platforms in global finance, even as Shaw’s own public role has shifted over time.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Comcast
CMCSA
|
+$354M |
| 2 |
Wells Fargo
WFC
|
+$274M |
| 3 |
IBM
IBM
|
+$266M |
| 4 |
Qualcomm
QCOM
|
+$257M |
| 5 |
Mondelez International
MDLZ
|
+$224M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$356M |
| 2 |
PayPal
PYPL
|
+$290M |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$261M |
| 4 |
NVIDIA
NVDA
|
+$248M |
| 5 |
AABA
Altaba Inc
AABA
|
+$245M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 14.31% |
| 2 | Healthcare | 10.66% |
| 3 | Consumer Discretionary | 10.29% |
| 4 | Communication Services | 8.78% |
| 5 | Financials | 8.21% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
251
PUT
AutoZone
AZO
$48.3B
| $62.1M | 0.1% |
104,300
+21,800
| +26% | +$11.6M |
|
|
EQC
252
DELISTED
Equity Commonwealth
EQC
| $62.1M | 0.1% |
2,041,746
-52,425
| -3% | -$1.62M |
|
253
American Electric Power
AEP
$65.8B
| $62M | 0.1% |
882,400
-284,700
| -24% | -$20.3M |
|
254
PUT
Bristol-Myers Squibb
BMY
$137B
| $61.5M | 0.09% |
965,000
-111,000
| -10% | -$6.48M |
|
255
Texas Instruments
TXN
$241B
| $61.1M | 0.09% |
681,374
-133,115
| -16% | -$10.9M |
|
256
F5
FFIV
$21.8B
| $60.8M | 0.09% |
504,677
+268,004
| +113% | +$32.4M |
|
257
United Airlines
UAL
$36.7B
| $60.8M | 0.09% |
998,631
+105,361
| +12% | +$7.02M |
|
258
PUT
Nike
NKE
$60.5B
| $60.5M | 0.09% |
1,166,100
+292,900
| +34% | +$16.4M |
|
259
Advanced Micro Devices
AMD
$773B
| $60.4M | 0.09% |
4,734,237
+1,540,966
| +48% | +$20.1M |
|
260
PUT
Costco
COST
$420B
| $60.2M | 0.09% |
366,600
+80,000
| +28% | +$12.6M |
|
261
Chemours
CC
$2.4B
| $60.1M | 0.09% |
1,188,435
-411,882
| -26% | -$19.4M |
|
|
CELG
262
CALL
DELISTED
Celgene Corp
CELG
| $60.1M | 0.09% |
412,100
+330,800
| +407% | +$45.1M |
|
|
263
PUT
Advanced Micro Devices
AMD
$773B
| $60M | 0.09% |
4,704,700
+2,706,700
| +135% | +$35.3M |
|
264
PUT
McDonald's
MCD
$192B
| $59.7M | 0.09% |
381,000
+137,000
| +56% | +$21.5M |
|
265
Carnival Corporation Ltd
CCL
$35.2B
| $59.2M | 0.09% |
916,265
+203,797
| +29% | +$13.6M |
|
266
Trane Technologies
TT
$99.8B
| $59.2M | 0.09% |
663,391
-225,961
| -25% | -$20M |
|
|
XEC
267
DELISTED
CIMAREX ENERGY CO
XEC
| $59M | 0.09% |
518,934
-407,198
| -44% | -$40.6M |
|
|
SYNH
268
DELISTED
Syneos Health, Inc. Class A Common Stock
SYNH
| $59M | 0.09% |
1,127,423
-337,896
| -23% | -$18.8M |
|
269
ConocoPhillips
COP
$162B
| $58.9M | 0.09% |
1,176,700
+701,727
| +148% | +$31.5M |
|
|
SGI
270
Somnigroup International
SGI
$13.6B
| $58.9M | 0.09% |
3,650,128
+1,279,336
| +54% | +$18.9M |
|
271
PUT
Ford
F
$57.5B
| $58.8M | 0.09% |
4,914,800
+640,400
| +15% | +$7.22M |
|
272
CALL
Cisco
CSCO
$438B
| $58.6M | 0.09% |
1,741,400
+3,700
| +0.2% | +$118K |
|
273
Newmont
NEM
$139B
| $58.5M | 0.09% |
1,560,465
-379,610
| -20% | -$13.8M |
|
|
ANDV
274
DELISTED
Andeavor
ANDV
| $58.4M | 0.09% |
566,070
-106,684
| -16% | -$10.5M |
|
|
AGN
275
PUT
DELISTED
Allergan plc
AGN
| $58.4M | 0.09% |
284,800
+115,000
| +68% | +$26.7M |
|
Similar funds
David Shaw's Q3 2017 Portfolio in Review
As of Q3 2017, David Shaw held 3,794 positions worth $65.1B, up 7.7% from $60.5B the previous quarter. Its ten largest holdings account for 9.6% of the portfolio.
David Shaw's Q3 2017 filing shows 469 new, 1,367 increased, 1,237 reduced and 370 closed positions. Its largest new stake was Baker Hughes: 3,076,914 shares worth $113M. The largest sale was Gilead Sciences, an estimated $356M.
By sector, the portfolio is most concentrated in Technology at 14% of assets, down from 14% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- David Shaw's largest Q3 2017 buy was Baker Hughes: 3,076,914 shares worth $113M.
- David Shaw added most to Comcast in Q3 2017, an estimated $354M increase.
- David Shaw's biggest Q3 2017 reduction was Gilead Sciences, cutting an estimated $356M.
- David Shaw fully exited Mobileye N.V. in Q3 2017, selling an estimated $72.4M.
- David Shaw's ten largest holdings make up 9.6% of its $65.1B portfolio in Q3 2017.
- David Shaw opened 469 new positions and closed 370 in Q3 2017.
- David Shaw's portfolio value rose 7.7% quarter-over-quarter to $65.1B.
Based on D.E. Shaw & Co's 13F filing for Q3 2017, filed 14 Nov 2017.